home.social

#remdesivir — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #remdesivir, aggregated by home.social.

fetched live
  1. In June we discharged the U.S. #Ebola patient fully recovered. Now #CharitéBerlin researchers share findings from his experimental treatment. Learn about symptoms, viral loads, and immune responses in our Paper spotlight:

    👉 charite.de/en/research/paper_s

    #CharitéPaper #Bundibugyo #MBP134 #remdesivir #medicine #science #research #ScienceMastodon

  2. In June we discharged the U.S. #Ebola patient fully recovered. Now #CharitéBerlin researchers share findings from his experimental treatment. Learn about symptoms, viral loads, and immune responses in our Paper spotlight:

    👉 charite.de/en/research/paper_s

    #CharitéPaper #Bundibugyo #MBP134 #remdesivir #medicine #science #research #ScienceMastodon

  3. In June we discharged the U.S. #Ebola patient fully recovered. Now #CharitéBerlin researchers share findings from his experimental treatment. Learn about symptoms, viral loads, and immune responses in our Paper spotlight:

    👉 charite.de/en/research/paper_s

    #CharitéPaper #Bundibugyo #MBP134 #remdesivir #medicine #science #research #ScienceMastodon

  4. In June we discharged the U.S. #Ebola patient fully recovered. Now #CharitéBerlin researchers share findings from his experimental treatment. Learn about symptoms, viral loads, and immune responses in our Paper spotlight:

    👉 charite.de/en/research/paper_s

    #CharitéPaper #Bundibugyo #MBP134 #remdesivir #medicine #science #research #ScienceMastodon

  5. In June we discharged the U.S. #Ebola patient fully recovered. Now #CharitéBerlin researchers share findings from his experimental treatment. Learn about symptoms, viral loads, and immune responses in our Paper spotlight:

    👉 charite.de/en/research/paper_s

    #CharitéPaper #Bundibugyo #MBP134 #remdesivir #medicine #science #research #ScienceMastodon

  6. Im Juni konnten wir den US-amerikanischen #Ebola-Patienten genesen entlassen. Jetzt haben #CharitéBerlin-Forschende seine experimentelle Behandlung wissenschaftlich aufgearbeitet. Mehr über Symptome, Viruslasten & Immunantworten in unserem Paper spotlight:

    👉 charite.de/forschung/paper_spo

    #CharitéPaper #Bundibugyo #MBP134 #Remdesivir #Medizin #Wissenschaft #Forschung #ScienceMastodon

  7. Im Juni konnten wir den US-amerikanischen #Ebola-Patienten genesen entlassen. Jetzt haben #CharitéBerlin-Forschende seine experimentelle Behandlung wissenschaftlich aufgearbeitet. Mehr über Symptome, Viruslasten & Immunantworten in unserem Paper spotlight:

    👉 charite.de/forschung/paper_spo

    #CharitéPaper #Bundibugyo #MBP134 #Remdesivir #Medizin #Wissenschaft #Forschung #ScienceMastodon

  8. Im Juni konnten wir den US-amerikanischen #Ebola-Patienten genesen entlassen. Jetzt haben #CharitéBerlin-Forschende seine experimentelle Behandlung wissenschaftlich aufgearbeitet. Mehr über Symptome, Viruslasten & Immunantworten in unserem Paper spotlight:

    👉 charite.de/forschung/paper_spo

    #CharitéPaper #Bundibugyo #MBP134 #Remdesivir #Medizin #Wissenschaft #Forschung #ScienceMastodon

  9. Im Juni konnten wir den US-amerikanischen #Ebola-Patienten genesen entlassen. Jetzt haben #CharitéBerlin-Forschende seine experimentelle Behandlung wissenschaftlich aufgearbeitet. Mehr über Symptome, Viruslasten & Immunantworten in unserem Paper spotlight:

    👉 charite.de/forschung/paper_spo

    #CharitéPaper #Bundibugyo #MBP134 #Remdesivir #Medizin #Wissenschaft #Forschung #ScienceMastodon

  10. Im Juni konnten wir den US-amerikanischen #Ebola-Patienten genesen entlassen. Jetzt haben #CharitéBerlin-Forschende seine experimentelle Behandlung wissenschaftlich aufgearbeitet. Mehr über Symptome, Viruslasten & Immunantworten in unserem Paper spotlight:

    👉 charite.de/forschung/paper_spo

    #CharitéPaper #Bundibugyo #MBP134 #Remdesivir #Medizin #Wissenschaft #Forschung #ScienceMastodon

  11. #Ebola treatment trial begins in Congo as outbreak continues to grow - Australia News Beep | NewsBeep.com

    Remdesivir or MBP134 or Remdesivir + MBP134

    #Remdesivir #MBP134 #Bundibugyo

    newsbeep.com/au/780555/

  12. #Ebola treatment trial begins in Congo as outbreak continues to grow - Australia News Beep | NewsBeep.com

    Remdesivir or MBP134 or Remdesivir + MBP134

    #Remdesivir #MBP134 #Bundibugyo

    newsbeep.com/au/780555/

  13. #Ebola treatment trial begins in Congo as outbreak continues to grow - Australia News Beep | NewsBeep.com

    Remdesivir or MBP134 or Remdesivir + MBP134

    #Remdesivir #MBP134 #Bundibugyo

    newsbeep.com/au/780555/

  14. #Ebola treatment trial begins in Congo as outbreak continues to grow - Australia News Beep | NewsBeep.com

    Remdesivir or MBP134 or Remdesivir + MBP134

    #Remdesivir #MBP134 #Bundibugyo

    newsbeep.com/au/780555/

  15. #Ebola treatment trial begins in Congo as outbreak continues to grow - Australia News Beep | NewsBeep.com

    Remdesivir or MBP134 or Remdesivir + MBP134

    #Remdesivir #MBP134 #Bundibugyo

    newsbeep.com/au/780555/

  16. WHO launches PARTNERS clinical trial for Bundibugyo virus treatments

    In a major international effort to evaluate potential treatments for Ebola disease due to Bundibugyo virus (BVD), the…
    #NewsBeep #News #Health #Antibody #AU #Australia #clinicaltrial #Ebolavirusdisease #medicine #MonoclonalAntibody #pandemic #publichealth #Remdesivir #research #Therapeutics #virus
    newsbeep.com/au/776560/

  17. WHO launches PARTNERS clinical trial for Bundibugyo virus treatments

    In a major international effort to evaluate potential treatments for Ebola disease due to Bundibugyo virus (BVD), the…
    #NewsBeep #News #Health #Antibody #AU #Australia #clinicaltrial #Ebolavirusdisease #medicine #MonoclonalAntibody #pandemic #publichealth #Remdesivir #research #Therapeutics #virus
    newsbeep.com/au/776560/

  18. Timing of #Remdesivir Initiation and Clinical #Outcomes in Hospitalized Patients with #COVID19 Who Are at High Risk of Disease Progression in #Japan: A Health Insurance Claims Database Study, etidiohnew.blogspot.com/2026/0

  19. Timing of #Remdesivir Initiation and Clinical #Outcomes in Hospitalized Patients with #COVID19 Who Are at High Risk of Disease Progression in #Japan: A Health Insurance Claims Database Study, etidiohnew.blogspot.com/2026/0

  20. Timing of #Remdesivir Initiation and Clinical #Outcomes in Hospitalized Patients with #COVID19 Who Are at High Risk of Disease Progression in #Japan: A Health Insurance Claims Database Study, etidiohnew.blogspot.com/2026/0

  21. Timing of #Remdesivir Initiation and Clinical #Outcomes in Hospitalized Patients with #COVID19 Who Are at High Risk of Disease Progression in #Japan: A Health Insurance Claims Database Study, etidiohnew.blogspot.com/2026/0

  22. Timing of #Remdesivir Initiation and Clinical #Outcomes in Hospitalized Patients with #COVID19 Who Are at High Risk of Disease Progression in #Japan: A Health Insurance Claims Database Study, etidiohnew.blogspot.com/2026/0

  23. #Remdesivir: Effectiveness and Safety in Hospitalized #COVID19 #Patients—Analysis of Retrospectively Collected Data from Daily Practice in #Omicron Variant Era and Comparison with the Pre-Omicron Period, etidiohnew.blogspot.com/2025/0

  24. #Remdesivir: Effectiveness and Safety in Hospitalized #COVID19 #Patients—Analysis of Retrospectively Collected Data from Daily Practice in #Omicron Variant Era and Comparison with the Pre-Omicron Period, etidiohnew.blogspot.com/2025/0

  25. #Remdesivir: Effectiveness and Safety in Hospitalized #COVID19 #Patients—Analysis of Retrospectively Collected Data from Daily Practice in #Omicron Variant Era and Comparison with the Pre-Omicron Period, etidiohnew.blogspot.com/2025/0

  26. #Remdesivir: Effectiveness and Safety in Hospitalized #COVID19 #Patients—Analysis of Retrospectively Collected Data from Daily Practice in #Omicron Variant Era and Comparison with the Pre-Omicron Period, etidiohnew.blogspot.com/2025/0

  27. #Remdesivir: Effectiveness and Safety in Hospitalized #COVID19 #Patients—Analysis of Retrospectively Collected Data from Daily Practice in #Omicron Variant Era and Comparison with the Pre-Omicron Period, etidiohnew.blogspot.com/2025/0